References
- Chu, P.L., Lin, Y., and Shih, W.J. (2009), “Unifying CRM and EWOC Designs for Phase I Cancer Clinical Trials,” Journal of Statistical Planning and Inference, 139, 1146–1163.
- Geoerger, B., Vassal, G., Doz, F., O’Quigley, J., Wartelle, M., Watson, A.J., Raquin, M.A., Frappaz, D., Chastagner, P., Gentet, J.C., Rubie, H., Couanet, D., Geoffray, A., Djafari, L., Margison, G.P., and Pein, F. (2005), “Dose Finding and O6-Alkylguanine-DNA Alkyltransferase Study of Cisplatin Combined With Temozolomide in Paediatric Solid Malignancies,” British Journal of Cancer, 93, 529–537.
- Iasonos, A., and O’Quigley, J. (2012), “Interplay of Priors and Skeletons in Two-Stage Continual Reassessment Method,” Statistics in Medicine, 31, 4321–4336.
- O’Quigley, J. (2005), “Retrospective Analysis of Sequential Dose-Finding Designs,” Biometrics, 61, 749–756.
- O’Quigley, J., Pepe, M., and Fisher, L. (1990), “Continual Reassessment Method: A Practical Design for Phase I Clinical Trials in Cancer,” Biometrics, 46, 33–48.
- O’Quigley, J., and Reiner, E. (1998), “A Stopping Rule for the Continual Reassessment Method,” Biometrika, 85, 741–748.
- O’Quigley, J., Paoletti, X., Maccario, J. (2002), “Non-parametric Optimal Design in Dose Finding Studies,” Biostatistics, 3, 51–56.
- O’Quigley, J., Shen, L., and Gamst, A. (1999), “Two-Sample Continual Reassessment Method,” Journal of Biopharmaceutical Statistics, 9, 17–44.
- Shen, L.Z., and O’Quigley, J. (1996), “Consistency of Continual Reassessment Method in Dose Finding Studies,” Biometrika, 83, 395–406.
- Yuan, Y., and Yin, G. (2011), “Dose-Response Curve Estimation: A Semiparametric Mixture Approach,” Biometrics, 67, 1543–1554.